NO3-rich Beet Juice and Exercise on Postmenopausal Women Cardiovascular Health

Last updated: January 10, 2023
Sponsor: University of Sao Paulo
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes And Hypertension

Stress

Female Hormonal Deficiencies/abnormalities

Treatment

N/A

Clinical Study ID

NCT05384340
BeetMPH5070
  • Ages 50-65
  • Female

Study Summary

In the context of physical exercise, there is no evidence of the acute and continued use of beetroot juice with a previously recommended dose of nitrate (NO3) (>300mg) on the cardiovascular performance of hypertensive and postmenopausal women. We will investigate the effects of beetroot juice rich in NO3 acutely (first day: 140mL/800mg) and during a week with daily doses (second to the seventh day: 70mL/400mg) on blood pressure, heart rate (HR), cardiac autonomic control, EF, inflammatory, hormonal, and stress biomarkers oxidative stress and enzymes involved in nitric oxide synthesis and mitochondrial regulation, under resting conditions, as well as mediated by submaximal aerobic exercise sessions. Through a randomized, crossover, triple-blind, placebo-controlled clinical trial, 20 physically inactive hypertensive women will undergo an acute and 7-day trial, each with two intervention protocols: 1) placebo and 2) beetroot; in which will ingest beet juice with or without NO3 in its composition with a 7-day washout interval. On collection days, exercise will be performed on a treadmill for 40 minutes at a speed corresponding to 65-70% of VO2peak. The collection of variables (cardiovascular, autonomic, and blood samples for molecular analyses) of the study will take place at rest (120 minutes after ingestion of the intervention), during exercise (40 minutes), and in the effort recovery stage (during 65 minutes) based on previously validated protocols. The collections were arranged so that the measurement of one variable does not interfere with the other and that they have adequate intervals between them.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Women with 50 to 65 old years;
  • Physically inactive;
  • Postmenopausal diagnosis (amenorrhea for 12 months or more);
  • Arterial hypertension diagnosis (previously);
  • Systolic blood pressure values >120mmHg up to 159mmHg and diastolic blood pressurevalues >80mmHg up to 99mmHg.

Exclusion

Exclusion Criteria:

  • Previous history of acute myocardial infarction and/or stroke;
  • Allergy or intolerance to nitrate, gluten, or milk;
  • Medications (proton pump inhibitors, beta-blockers, calcium channels antagonists).

Study Design

Total Participants: 20
Study Start date:
May 31, 2022
Estimated Completion Date:
July 30, 2024

Connect with a study center

  • EEFERP - USP / Laboratório de Fisiologia do Exercício e Metabolismo

    Ribeirão Preto, São Paulo
    Brazil

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.